Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Nº S1 (2022)
- Ano: 2022
- Artigos: 228
- URL: https://journals.eco-vector.com/2412-4036/issue/view/6615
Articles
Izuchenie markerov vospaleniya u bol'nykh ishemicheskoy bolezn'yu serdtsa posle stentirovaniya koronarnykh arteriy
Therapy. 2022;(S1):2-2
2-2
Osobennosti novoy koronavirusnoy infektsii pri razvitii ostrogo povrezhdeniya pochek
Therapy. 2022;(S1):2-3
2-3
Techenie novoy koronavirusnoy infektsii pri khronicheskoy bolezni pochek
Therapy. 2022;(S1):3-4
3-4
Otsenka urovney IL-6, IL-8, IL-10, TNF-α krovi u patsientov s autoimmunnymi zabolevaniyami pecheni v zavisimosti ot vnepechenochnykh proyavleniy
Therapy. 2022;(S1):4-4
4-4
Izmenenie pronitsaemosti tonkoy kishki u patsientov s sindromom perekresta (autoimmunnyy gepatit/pervichnyy biliarnyy kholangit)
Therapy. 2022;(S1):4-5
4-5
Patsient s COVID-19 - mul'tidistsiplinarnyy patsient
Therapy. 2022;(S1):5-5
5-5
Antidepressanty v terapii sindroma razdrazhennogo kishechnika
Therapy. 2022;(S1):5-6
5-6
Effektivnye i bezopasnye podkhody k lecheniyu i reabilitatsii patsientov stabil'noy koronarnoy bolezn'yu serdtsa posle planovoy revaskulyarizatsii miokarda
Therapy. 2022;(S1):6-7
6-7
Osobennosti sutochnogo monitorirovaniya arterial'nogo davleniya u patsientov s izolirovannoy arterial'noy gipertenziey i v sochetanii s varikoznoy bolezn'yu ven nizhnikh konechnostey
Therapy. 2022;(S1):7-7
7-7
Klinicheskaya otsenka faktorov riska neblagopriyatnogo prognoza professional'noy bronkhial'noy astmy, assotsiirovannoy s lekarstvennoy allergiey
Therapy. 2022;(S1):7-8
7-8
Faktory riska prekapillyarnoy legochnoy gipertenzii pri professional'noy obstruktivnoy bolezni legkikh u gazoelektrosvarshchikov
Therapy. 2022;(S1):8-9
8-9
Novye podkhody k optimizatsii terapii professional'noy bronkhial'noy astmy s fiksirovannoy bronkhial'noy obstruktsiey
Therapy. 2022;(S1):9-9
9-9
Osobennosti farmakoterapii u komorbidnykh bol'nykh s ostroy SARS-CoV-2-infektsiey
Therapy. 2022;(S1):10-10
10-10
Sostoyanie sistemy immuniteta u sotrudnikov Astrakhanskogo gazovogo kompleksa s patologiey gepatobilliarnoy sistemy v zavisimosti ot stazha raboty na predpriyatii
Therapy. 2022;(S1):10-11
10-11
Rentgenologicheskie osobennosti pnevmonii, assotsiirovannoy s novoy koronavirusnoy infektsiey SOVID-19
Therapy. 2022;(S1):11-12
11-12
Kliniko-patogeneticheskie osobennosti sakharnogo diabeta 2 tipa u bol'nykh khronicheskoy obstruktivnoy bolezn'yu legkikh na fone tuberkuleza legkikh
Therapy. 2022;(S1):12-12
12-12
Agregatsionnaya aktivnost' trombotsitov u patsientov s postkovidnym sindromom na etape meditsinskoy reabilitatsii
Therapy. 2022;(S1):12-13
12-13
Vyyavlenie odnonukleotidnykh polimorfizmov struktury beta-adrenoretseptorov i otsenka adrenoreaktivnosti u patsientov, stradayushchikh bronkhial'noy astmoy
Therapy. 2022;(S1):13-14
13-14
Faktory, sposobstvuyushchie otkazu ot tabakokureniya, i vidy kognitivnykh iskazheniy u lits s razlichnym statusom kureniya
Therapy. 2022;(S1):14-14
14-14
Chastota razvitiya trombozov golometallicheskikh i pokrytykh koronarnykh stentov u patsientov s ostrym infarktom miokarda na fone trombotsitopenii
Therapy. 2022;(S1):14-15
14-15
Vliyanie trombotsitopenii na risk razvitiya trombozov koronarnogo stenta u patsientov s ostrym infarktom miokarda
Therapy. 2022;(S1):15-15
15-15
Pokazateli endotelial'noy disfunktsii, kak marker subklinicheskogo ateroskleroza u bol'nykh volchanochnym nefritom
Therapy. 2022;(S1):15-16
15-16
Dinamika plotnosti kollagena i ekspressii faktorov rosta fibroblastov v zheludochkakh serdtsa krys linii Vistar pod vliyaniem adrenalina
Therapy. 2022;(S1):16-17
16-17
Diabeticheskaya nefropatiya kak odno iz samykh rasprostranennykh oslozhneniy sakharnogo diabeta. Analiz dannykh federal'nogo registra v Khanty-Mansiyskom avtonomnom okruge - Yugre za 2021 god
Therapy. 2022;(S1):17-18
17-18
Vedushchie oslozhneniya sakharnogo diabeta. Otsenka dannykh okruzhnogo registra za 2021 god
Therapy. 2022;(S1):18-18
18-18
Gemostazreguliruyushchaya funktsiya legkikh v dinamike novoy koronavirusnoy infektsii
Therapy. 2022;(S1):18-19
18-19
Tsitokiny i vospalenie u patsientov s kardiovaskulyarnoy patologiey
Therapy. 2022;(S1):19-19
19-19
Funktsional'nyy status i otsenka pitaniya bol'nykh pozhilogo i starcheskogo vozrasta s serdechno-sosudistymi zabolevaniyami
Therapy. 2022;(S1):20-20
20-20
Vzaimosvyaz' techeniya bolezni Krona s porazheniem sustavov i entezisov
Therapy. 2022;(S1):20-21
20-21
Kliniko-ul'trazvukovoe sopostavlenie porazheniya entezisov pri vospalitel'nykh zabolevaniyakh kishechnika
Therapy. 2022;(S1):21-21
21-21
Kliniko-ul'trazvukovoe sopostavlenie porazheniya sustavov pri vospalitel'nykh zabolevaniyakh kishechnika
Therapy. 2022;(S1):21-22
21-22
Kognitivnaya disfunktsiya i narusheniya khod'by pri gipertonicheskoy entsefalopatii
Therapy. 2022;(S1):22-22
22-22
Assotsiatsiya bessimptomnogo povysheniya urovnya mochevoy kisloty s drugimi zabolevaniyami
Therapy. 2022;(S1):22-23
22-23
Printsipy razrabotki sistemy mer po okhrane zdorov'ya rabochikh neftedobychi
Therapy. 2022;(S1):23-24
23-24
Rasstroystvo sna kak vozmozhnaya sostavlyayushchaya serdechno-sosudistogo riska
Therapy. 2022;(S1):24-24
24-24
Chastota ispol'zovaniya GIBP dlya lecheniya patsientov s psoriaticheskim artritom
Therapy. 2022;(S1):24-25
24-25
Otsenka neblagopriyatnogo prognoza v techenie goda posle ostrogo infarkta miokarda u muzhchin molozhe 45 let
Therapy. 2022;(S1):25-25
25-25
Vliyanie khronicheskoy obstruktivnoy bolezni legkikh na techenie serdechno-sosudistoy patologii u lits pozhilogo vozrasta
Therapy. 2022;(S1):25-26
25-26
K voprosu ob otsenke prognosticheskoy znachimosti faktorov riska razvitiya ostrogo povrezhdeniya pochek pri infarkte miokarda u muzhchin molodogo i srednego vozrasta
Therapy. 2022;(S1):26-27
26-27
Rol' vegetativnoy regulyatsii serdechnoy deyatel'nosti v patogeneze serdechnoy nedostatochnosti s sokhranennoy fraktsiey vybrosa
Therapy. 2022;(S1):27-27
27-27
Osobennosti vyzhivshikh i umershikh patsientov s khronicheskoy serdechnoy nedostatochnost'yu starcheskogo vozrasta, gospitalizirovannykh v statsionar
Therapy. 2022;(S1):27-28
27-28
Analiz bezopasnosti primeneniya genno-inzhenernykh biologicheskikh preparatov v lechenii revmatoidnogo artrita
Therapy. 2022;(S1):28-29
28-29
Vzaimosvyaz' sortilina i proproteinovoy konvertazy subtilizin-keksinovogo tipa 9 syvorotki krovi s tyazhest'yu karotidnogo i koronarnogo ateroskleroza u patsientov s raznym sutochnym profilem arterial'nogo davleniya
Therapy. 2022;(S1):29-29
29-29
Kharakteristika zhelezodefitsitnykh sindromov u patsientov s khronicheskoy serdechnoy nedostatochnost'yu, prognozirovanie laboratornoy effektivnosti peroral'nymi preparatami zheleza
Therapy. 2022;(S1):29-30
29-30
Prediktory otdalennykh neblagopriyatnykh serdechno-sosudistykh sobytiy pri sakharnom diabete 2 tipa
Therapy. 2022;(S1):30-30
30-30
Otsenka techeniya koronavirusnoy infektsii u vaktsinirovannykh patsientov
Therapy. 2022;(S1):30-31
30-31
31-32
Analiz ispol'zovaniya elektronno-vychislitel'nykh modeley shkal SCORE-2 I SCORE2-OP s tsel'yu kontrolya serdechno-sosudistogo riska i sosudistogo vozrasta u patsientov s arterial'noy gipertenziey
Therapy. 2022;(S1):32-33
32-33
Vliyanie khronicheskoy bolezni pochek na techenie COVID-19 u bol'nykh s ishemicheskim insul'tom
Therapy. 2022;(S1):33-33
33-33
Endotelial'naya funktsiya u patsientov s vpervye vyyavlennym sakharnym diabetom 2 tipa
Therapy. 2022;(S1):33-34
33-34
Analiz sluchaev lekarstvennoy gepatotoksichnosti
Therapy. 2022;(S1):34-34
34-34
Osobennosti radionuklidnoy diagnostiki gastroezofageal'nogo reflyuksa u patsientov s sistemnoy sklerodermiey
Therapy. 2022;(S1):34-35
34-35
Otsenka strategiy sovladayushchego povedeniya u patsientov posle implantatsii iskusstvennogo voditelya ritma
Therapy. 2022;(S1):35-35
35-35
Vliyanie sotsial'no-ekonomicheskoy i ekologicheskoy deprivatsii na razvitie metabolicheskogo sindroma
Therapy. 2022;(S1):35-36
35-36
Pokazateli raboty meditsinskikh uchrezhdeniy Orenburgskoy oblasti v realizatsii proekta «Bor'ba s serdechno-sosudistymi zabolevaniyami»
Therapy. 2022;(S1):36-37
36-37
Korrektsiya kognitivnykh narusheniy u patsientov s metabolicheskim sindromom
Therapy. 2022;(S1):37-37
37-37
Osobennosti proyavleniya gepatorenal'nogo sindroma u bol'nykh tsirrozom pecheni
Therapy. 2022;(S1):37-38
37-38
Soderzhanie vitamina D u patsientov s khronicheskoy serdechnoy nedostatochnost'yu
Therapy. 2022;(S1):38-38
38-38
Otsenka riska sakharnogo diabeta 2-go tipa po shkale FINDRISK v gruppe ambulatornykh patsientov s arterial'noy gipertenziey
Therapy. 2022;(S1):39-39
39-39
Konstitutsional'nye osobennosti ob\"ema i formy shchitovidnoy zhelezy u zhenshchin
Therapy. 2022;(S1):39-40
39-40
Kliniko-funktsional'nye i psikhovegetativnye pokazateli u patsientov s deformiruyushchim osteoartritom kolennykh sustavov vysokogo riska sosudistykh oslozhneniy v dinamike lecheniya
Therapy. 2022;(S1):40-40
40-40
Osobennosti techeniya postkovidnogo sindroma u rekonvalestsentov COVID-19
Therapy. 2022;(S1):40-41
40-41
Izuchenie pokazateley renin-angiotenzin-al'dosteronovoy sistemy u bol'nykh khronicheskoy serdechnoy nedostatochnost'yu, perenesshikh COVID-19
Therapy. 2022;(S1):41-41
41-41
Mobil'noe prilozhenie dlya otsenki prognoza u bol'nykh khronicheskoy serdechnoy nedostatochnost'yu s uchetom funktsional'nogo sostoyaniya pochek
Therapy. 2022;(S1):41-42
41-42
Osobennosti proyavleniya gepatorenal'nogo sindroma u bol'nykh tsirrozom pecheni
Therapy. 2022;(S1):42-42
42-42
Vliyanie affektivnykh rasstroystv na techenie khronicheskoy serdechnoy nedostatochnosti u ambulatornykh patsientov
Therapy. 2022;(S1):43-43
43-43
Personalizirovannaya terapiya arterial'noy gipertenzii u patsientov pozhilogo vozrasta starshe 60 let
Therapy. 2022;(S1):43-44
43-44
Chastota vstrechaemosti arterial'nykh tromboembolicheskikh sobytiy u patsientov s kardiologicheskoy patologiey, perebolevshikh COVID-19, rol' antikoagulyantov
Therapy. 2022;(S1):44-45
44-45
Prezhdevremennoe starenie zhenshchin s displaziey soedinitel'noy tkani
Therapy. 2022;(S1):45-45
45-45
Serdechnaya nedostatochnost' s sokhranennoy fraktsiey vybrosa: rol' mikrovaskulyarnoy disfunktsii
Therapy. 2022;(S1):45-46
45-46
Variabel'nost' serdechnogo ritma pri khronicheskoy serdechnoy nedostatochnosti
Therapy. 2022;(S1):46-46
46-46
Prognosticheskaya rol' koronarnoy mikrovaskulyarnoy disfunktsii v razvitii i progressirovanii serdechnoy nedostatochnosti s sokhranennoy fraktsiey vybrosa
Therapy. 2022;(S1):46-47
46-47
Otsenka effektivnosti i bezopasnosti primeneniya statinoterapii i v kombinatsii s ezetimibom u bol'nykh, perenesshikh infarkt miokarda
Therapy. 2022;(S1):47-47
47-47
Gendernye osobennosti techeniya i lecheniya ostrogo infarkta
Therapy. 2022;(S1):48-48
48-48
Veroyatnost' smerti patsienta s infarktom miokarda v statsionare vo vremya pandemii
Therapy. 2022;(S1):48-48
48-48
COVID-19 i khronicheskie zabolevaniya pecheni: baza dannykh GKB imeni V. M. Buyanova DZM
Therapy. 2022;(S1):48-49
48-49
O vzaimosvyazi klinicheskikh proyavleniy postinfektsionnogo glomerulonefrita s funtsional'nym sostoyaniem shchitovidnoy zhelezy
Therapy. 2022;(S1):49-50
49-50
Opyt primeneniya vaktsin otechestvennogo proizvodstva protiv COVID-19 u patsientov s revmaticheskimi zabolevaniyami (predvaritel'nye dannye)
Therapy. 2022;(S1):50-50
50-50
Proyavleniya astenii u patsientov s vospalitel'nymi zabolevaniyami kishechnika v postkovidnom periode
Therapy. 2022;(S1):50-51
50-51
Chastota razvitiya postkovidnogo sindroma u patsientov s vospalitel'nymi zabolevaniyami kishechnika
Therapy. 2022;(S1):51-52
51-52
Kharakter techeniya vospalitel'nykh zabolevaniy kishechnika v postkovidnom periode
Therapy. 2022;(S1):52-52
52-52
Otsenka kachestva zhizni u bol'nykh funktsional'noy dispepsiey
Therapy. 2022;(S1):52-53
52-53
Anemiya i bolevoy sindrom pri revmatoidnom artrite kak prediktory porazheniya krupnykh sustavov s neobkhodimost'yu ikh endoprotezirovaniya
Therapy. 2022;(S1):53-53
53-53
Osteoporoz pri revmatoidnom artrite kak faktor razvitiya disfunktsii miokarda i uvelicheniya serdechno-sosudistogo riska
Therapy. 2022;(S1):53-54
53-54
Tolerantnost' k fizicheskoy nagruzke u bol'nykh tsirrozami pecheni
Therapy. 2022;(S1):54-54
54-54
Vliyanie fizicheskikh trenirovok na strukturno-funktsional'noe sostoyanie pravogo zheludochka serdtsa u bol'nykh s khronicheskoy serdechnoy nedostatochnost'yu starshe 60 let: pol'za ili vred
Therapy. 2022;(S1):54-55
54-55
Sravnitel'naya kharakteristika fenotipov serdechnoy nedostatochnosti u patsientov starshego vozrasta
Therapy. 2022;(S1):55-56
55-56
EKG-telemetriya v protsesse kardioreabilitatsii
Therapy. 2022;(S1):56-56
56-56
Dinamika sistolicheskoy i diastolicheskoy funktsii levogo zheludochka pri polimorfizme gena sintazy oksida azota u patsientov posle aortokoronarnogo shuntirovaniya
Therapy. 2022;(S1):56-57
56-57
Sluchay povtornogo postkovidnogo perikardita
Therapy. 2022;(S1):57-58
57-58
Virus TT (Torque Teno Virus) i ego znachenie dlya zabolevaniy pecheni
Therapy. 2022;(S1):58-58
58-58
Osobennosti sostoyaniya lipidov, massy tela i ikh assotsiatsiya s prezhdevremennym stareniem muzhchin zrelogo vozrasta, stradayushchikh arterial'noy gipertoniey
Therapy. 2022;(S1):58-59
58-59
Rol' novogo klassa preparatov - ingibitorov PSCK-9 v sud'be komorbidnogo patsienta
Therapy. 2022;(S1):59-59
59-59
NDST kak faktor riska razvitiya psikhovegetativnykh rasstroystv i khronicheskoy ishemii golovnogo mozga u lits molodogo vozrasta
Therapy. 2022;(S1):59-60
59-60
Opyt primeneniya vspomogatel'noy intranazal'noy ventilyatsii legkikh u bol'nykh s perenesennoy polisegmentarnoy pnevmoniey
Therapy. 2022;(S1):60-61
60-61
Importozameshchenie v terapevticheskom statsionare kak komponent uluchsheniya okazaniya kachestva meditsinskoy pomoshchi
Therapy. 2022;(S1):61-61
61-61
Fenotipicheskie osobennosti techeniya gastroezofageal'noy reflyuksnoy bolezni pri ee komorbidnosti s ozhireniem
Therapy. 2022;(S1):62-62
62-62
Farmakoekonomicheskaya otsenka primeneniya genotipirovaniya pri naznachenii dabigatrana u patsientov s fibrillyatsiey predserdiy i khronicheskoy bolezn'yu pochek
Therapy. 2022;(S1):62-63
62-63
Effektivnost' parenteral'nogo vvedeniya betametazona dlya profilaktiki i lecheniya sistemnoy vospalitel'noy reaktsii u ambulatornykh patsientov v ostroy faze pul'monal'noy formy COVID-19
Therapy. 2022;(S1):63-64
63-64
Primenenie lanadelumaba dlya dolgosrochnoy profilaktiki u patsientki s nasledstvennym angionevroticheskim otekom
Therapy. 2022;(S1):64-64
64-64
Kliniko-funktsional'nye i prognosticheskie osobennosti metabolizma beta-2-mikroglobulina u bol'nykh s khronicheskoy bolezn'yu pochek v zavisimosti ot mesta prozhivaniya
Therapy. 2022;(S1):65-65
65-65
Analiz techeniya revmatoidnogo artrita u patsientov v postkovidnom periode v Respublike Tatarstan
Therapy. 2022;(S1):65-66
65-66
Chastota vozniknoveniya astenovegetativnogo sindroma u patsientov s revmatoidnym artritom posle perenesennogo COVID-19 v Respublike Tatarstan
Therapy. 2022;(S1):66-67
66-67
Autoimmunitet k kollagenu I tipa u patsientov s vospalitel'nymi zabolevaniyami kishechnika
Therapy. 2022;(S1):67-67
67-67
Otsenka vliyaniya kureniya na sostoyanie pecheni u patsientov s psoriaticheskim artritom
Therapy. 2022;(S1):67-68
67-68
Novaya koronavirusnaya infektsiya COVID-19, oslozhnennaya razvitiem bystroprogressiruyushchego glomerulonefrita s obrazovaniem antitel k glomerulyarnoy bazal'noy membrane
Therapy. 2022;(S1):68-68
68-68
Strukturno-funktsional'nye izmeneniya miokarda u lits s arterial'noy gipertenziey i nalichiem starcheskoy astenii
Therapy. 2022;(S1):68-69
68-69
Vyzhivaemost' terapii ingibitorami FNOα u patsientov s razlichnymi immunovospalitel'nymi zabolevaniyami
Therapy. 2022;(S1):69-69
69-69
Osobennosti klinicheskikh priznakov gastroduodenal'nykh eroziy i yazv u bol'nykh s persistiruyushchey formoy fibrillyatsii predserdiy na fone lecheniya pryamymi peroral'nymi antikoagulyantami
Therapy. 2022;(S1):70-70
70-70
Latentnyy defitsit zheleza v obshchevrachebnoy praktike
Therapy. 2022;(S1):70-71
70-71
Monitoring rannikh narusheniy obmena kholesterina
Therapy. 2022;(S1):71-72
71-72
Otsenka effektivnosti dispanserizatsii opredelennykh grupp vzroslogo naseleniya v vyyavlenii bolezney sistemy krovoobrashcheniya
Therapy. 2022;(S1):72-72
72-72
Osobennosti tireoidnoy patologii, voznikayushchey v postkovidnom periode u patsientov s predshestvuyushchey vaktsinatsiey i bez nee
Therapy. 2022;(S1):72-72
72-72
Kharakteristika faktorov, vliyayushchikh na klinicheskoe techenie bronkhial'noy astmy v gestatsionnom periode
Therapy. 2022;(S1):73-73
73-73
Uroven' S-reaktivnogo proteina u bol'nykh obstruktivnoy bolezn'yu legkikh s razlichnoy vyrazhennost'yu nikotinovoy zavisimosti
Therapy. 2022;(S1):73-74
73-74
Sopostavlenie markerov vospaleniya i priverzhennosti k tabakokureniyu u bol'nykh infarktom miokarda na fone khronicheskoy obstruktivnoy bolezni legkikh
Therapy. 2022;(S1):74-74
74-74
Endoskopicheskie izmeneniya verkhnikh otdelov zheludochno-kishechnogo trakta bol'nykh khronicheskoy bolezn'yu pochek v terminal'noy stadii, poluchayushchikh lechenie gemodializom
Therapy. 2022;(S1):74-75
74-75
Nizkaya predtestovaya veroyatnost' ishemicheskoy bolezni serdtsa: analiz faktorov riska
Therapy. 2022;(S1):75-75
75-75
Omega-3 polinenasyshchennye zhirnye kisloty v profilaktike posleoperatsionnoy fibrillyatsii predserdiy
Therapy. 2022;(S1):75-76
75-76
Rasprostranennost' i klinicheskoe znachenie nevropaticheskogo komponenta khronicheskoy skeletno-myshechnoy boli i ego vliyaniya na risk padeniy u patsientov starshe 60 let
Therapy. 2022;(S1):76-76
76-76
Issledovanie mutatsiy v gene BCR: ABL u bol'nykh s khronicheskim mieloleykozom
Therapy. 2022;(S1):77-77
77-77
Perspektivy vedeniya komorbidnykh bol'nykh s perenesennoy infektsiey COVID-19
Therapy. 2022;(S1):77-78
77-78
Biomekhanika dykhaniya, diffuzionnaya sposobnost' legkikh, sila dykhatel'noy muskulatury i vyrazhennosti odyshki u patsientov, perenesshikh koronavirusnuyu pnevmoniyu
Therapy. 2022;(S1):78-79
78-79
Faktory, vliyayushchie na kachestvo ratsiona pitaniya patsientov s infarktom miokarda
Therapy. 2022;(S1):79-79
79-79
Premorbidnye effekty vozdeystviya shumo-vibratsionnogo faktora
Therapy. 2022;(S1):79-80
79-80
Vliyanie ozhireniya i pylevoy nagruzki na elasticheskie svoystva sosudistoy stenki
Therapy. 2022;(S1):80-80
80-80
Osobennosti pokazateley sutochnogo monitorirovaniya arterial'nogo davleniya u bol'nykh arterial'noy gipertenziey, sochetannoy s khronicheskoy obstruktivnoy bolezn'yu legkikh zloupotreblyayushchikh alkogolem
Therapy. 2022;(S1):81-81
81-81
Ekhokardiograficheskaya kharakteristika klapanov serdtsa u lits raznogo vozrasta s infektsionnym endokarditom posle novoy koronavirusnoy infektsii COVID-19
Therapy. 2022;(S1):81-82
81-82
Kliniko-funktsional'nye osobennosti regulyatsii serdechnogo ritma pri sindrome Marfana: rezul'taty prospektivnogo issledovaniya
Therapy. 2022;(S1):82-82
82-82
Otsenka komorbidnosti umershikh patsientov s novoy koronavirusnoy infektsiey
Therapy. 2022;(S1):82-83
82-83
Vozmozhnosti medikamentoznoy korrektsii kachestva zhizni u bol'nykh s khronicheskoy serdechnoy nedostatochnost'yu i khronicheskoy obstruktivnoy bolezn'yu legkikh
Therapy. 2022;(S1):83-84
83-84
Vliyanie epikardial'nogo zhira na strukturno-funktsional'noe sostoyanie serdtsa i serdechno-sosudistyy risk u bol'nykh s arterial'noy gipertenziey i nealkogol'noy zhirovoy bolezn'yu pecheni
Therapy. 2022;(S1):84-84
84-84
Svyaz' mezhdu steatozom pecheni i sostoyaniem mikrotsirkulyatsii u patsientov s nealkogol'noy zhirovoy bolezn'yu pecheni i khronicheskoy serdechnoy nedostatochnost'yu
Therapy. 2022;(S1):84-85
84-85
Znachenie giperurikemii u patsientov s khronicheskoy serdechnoy nedostatochnost'yu, nealkogol'noy zhirovoy bolezn'yu pecheni i khronicheskoy bolezn'yu pochek
Therapy. 2022;(S1):85-85
85-85
Vozmozhnost' ispol'zovaniya odnonukleotidnogo polimorfizma nekotorykh genov v prognozirovanii techeniya postkovidnogo sindroma u bol'nykh sakharnym diabetom 2 tipa
Therapy. 2022;(S1):86-86
86-86
Dostizheniya tselevykh znacheniy faktorov riska oslozhneniy u patsientovochen' vysokogo riska
Therapy. 2022;(S1):86-87
86-87
R-selektin kak marker endotelial'noy disfunktsii u patsientov so zlokachestvennymi novoobrazovaniyami
Therapy. 2022;(S1):87-87
87-87
Rasprostranennost' udlineniya intervala QT u patsientov s vospalitel'nymi zabolevaniyami kishechnika
Therapy. 2022;(S1):87-88
87-88
Prognosticheskoe znachenie disfunktsii pravogo zheludochka pri dekompensatsii khronicheskoy serdechnoy nedostatochnosti
Therapy. 2022;(S1):88-88
88-88
Muzhchiny molodogo vozrasta s infarktom miokarda i fenomenom zamedlennogo koronarnogo krovotoka: god posle indeksnogo sobytiya
Therapy. 2022;(S1):88-89
88-89
Interleykin-6 u bol'nykh ishemicheskoy bolezn'yu serdtsa v starcheskom vozraste
Therapy. 2022;(S1):89-89
89-89
Vzaimosvyaz' vitamina D i razlichnykh klinicheskikh i laboratornykh parametrov u bol'nykh starcheskogo vozrasta i dolgozhiteley s ishemicheskoy bolezn'yu serdtsa
Therapy. 2022;(S1):89-90
89-90
Bessimptomnaya giperurikemiya i zhestkost' sosudistoy stenki u patsientov s nealkogol'noy zhirovoy bolezn'yu pecheni
Therapy. 2022;(S1):90-91
90-91
Uroven' vitamina D v syvorotke krovi v gruppe patsientov s zabolevaniyami endokrinnoy sistemy
Therapy. 2022;(S1):91-91
91-91
Osobennosti kliniki COVID-19 u kardiologicheskikh patsientov polikliniki cherez 1 mesyats posle vyzdorovleniya
Therapy. 2022;(S1):91-92
91-92
Geneticheskie markery v otsenke neblagopriyatnogo prognoza techeniya khronicheskoy obstruktivnoy bolezni legkikh
Therapy. 2022;(S1):92-92
92-92
Kardiovaskulyarnye oslozhneniya pri novoy koronavirusnoy infektsii
Therapy. 2022;(S1):92-93
92-93
Korrelyatsii respiratornykh zhalob, kliniko-laboratornykh, ekhokardiograficheskikh i rentgenologicheskikh proyavleniy u patsientov s COVID-19
Therapy. 2022;(S1):93-94
93-94
Metody bal'neo- i fizioterapii v meditsinskoy reabilitatsii bol'nykh s zabolevaniyami sustavov, oslozhnennykh povyshennoy meteochuvstvitel'nost'yu
Therapy. 2022;(S1):94-94
94-94
Ul'trazvukovye osobennosti artrita i entezita v zavisimosti ot narusheniya fizicheskogo funktsionirovaniya pri psoriaticheskom artrite
Therapy. 2022;(S1):94-95
94-95
Osobennosti formirovaniya tipov remodelirovaniya miokarda u patsientov s revmatoidnym artritom
Therapy. 2022;(S1):95-95
95-95
Otsenka riska vnezapnoy smerti u patsientov s revmatoidnym artritom
Therapy. 2022;(S1):95-96
95-96
Rannyaya diagnostika disfunktsii miokarda u patsientov s revmaticheskimi zabolevaniyami
Therapy. 2022;(S1):96-96
96-96
Padeniya i revmatoidnyy artrit
Therapy. 2022;(S1):96-97
96-97
Sostoyanie vitamin-D obmena u perenesshikh COVID-19 patsientov s vpervye vyyavlennym sakharnym diabetom 2 tipa i komorbidnoy patologiy, prozhivayushchikh v Ryazani i Ryazanskoy oblasti
Therapy. 2022;(S1):97-97
97-97
Osobennosti kuratsii patsientov starcheskogo vozrasta s fibrillyatsiey predserdiy
Therapy. 2022;(S1):97-98
97-98
Proyavlenie bevatsizumab-indutsirovannoy arterial'noy gipertenzii u patsientov s kolorektal'nym rakom
Therapy. 2022;(S1):98-98
98-98
Padeniya - marker ukhudsheniya funktsional'nogo statusa u lits pozhilogo vozrasta bez starcheskoy astenii
Therapy. 2022;(S1):98-99
98-99
Metabolicheskie parametry v doklinicheskoy diagnostike sarkopenii u lits srednego vozrasta
Therapy. 2022;(S1):99-99
99-99
Sravnenie chastoty i tyazhest' osteoartrita u patsientov s podagroy i asimptomaticheskoy giperurikemiey: predvaritel'nye dannye
Therapy. 2022;(S1):99-100
99-100
Perspektivy primeneniya oksietilammoniya metilfenoksiatsetata u patsientov, perenesshikh COVID-19
Therapy. 2022;(S1):100-100
100-100
Korrektsiya anemii u patsientov, perenesshikh COVID-19
Therapy. 2022;(S1):100-101
100-101
Osobennosti lechebnogo pitaniya v kompleksnoy terapii u patsientov s diabeticheskoy nefropatiey
Therapy. 2022;(S1):101-101
101-101
Nemedikamentoznoe vosstanovlenie ritma stula s pomoshch'yu natural'noy mineral'noy vody u molodykh i pozhilykh patsientov
Therapy. 2022;(S1):101-102
101-102
Sindrom bradienterii povyshaet risk ozhireniya i arterial'noy gipertenzii
Therapy. 2022;(S1):102-103
102-103
Pokazateli indutsirovannogo okisleniya krovi i posleoperatsionnye oslozhneniya pri revaskulyarizatsii miokarda
Therapy. 2022;(S1):103-103
103-103
Nekotorye aspekty patogeneza immunovospalitel'nykh zabolevaniy
Therapy. 2022;(S1):103-104
103-104
Klinicheskoe znachenie polimorfizma genov KCNJ11 i TCF7L2 u bol'nykh s vpervye vyyavlennym sakharnym diabetom 2 tipa pri terapii vildagliptinom
Therapy. 2022;(S1):104-104
104-104
Osobennosti legochnoy gipertenzii pri serdechnoy nedostatochnosti posle perenesennoy novoy koronavirusnoy infektsii COVID-19
Therapy. 2022;(S1):105-105
105-105
Vliyanie koronavirusnoy infektsii SOVID-19 na pokazateli perifericheskoy tsirkulyatsii u bol'nykh gipertonicheskoy bolezn'yu
Therapy. 2022;(S1):105-106
105-106
Uroven' prokal'tsitonina u bol'nykh s COVID-19 na fone arterial'noy gipertenzii
Therapy. 2022;(S1):106-106
106-106
Rezul'taty 10-letnego nablyudeniya dinamiki techeniya pnevmokoniozov, professional'nykh bronkhitov i khronicheskoy obstruktivnoy bolezni legkikh v Permskom krae
Therapy. 2022;(S1):107-107
107-107
Prognosticheskoe znachenie N-terminal'nogo fragmenta mozgovogo natriyureticheskogo peptida u bol'nykh s podagroy
Therapy. 2022;(S1):107-108
107-108
Trendy smertnosti, komorbidnosti i lecheniya posle infarkta miokarda u patsientov s revmatoidnym artritom v Stavropol'skom krae
Therapy. 2022;(S1):108-108
108-108
Faktory kardiometabolicheskogo riska u molodykh muzhchin pri nealkogol'noy zhirovoy bolezni pecheni
Therapy. 2022;(S1):108-109
108-109
Infarkt miokarda s pod\"emom segmenta ST na fone novoy koronavirusnoy infektsii COVID-19: kliniko-laboratornye pokazateli i chastota oslozhneniy
Therapy. 2022;(S1):109-109
109-109
Osobennosti novoy koronavirusnoy infektsii pri razvitii ostrogo povrezhdeniya pochek
Therapy. 2022;(S1):110-110
110-110
Techenie novoy koronavirusnoy infektsii pri khronicheskoy bolezni pochek
Therapy. 2022;(S1):110-111
110-111
Klinicheskie kharakteristiki i molekulyarnye markery gipermobil'nosti sustavov u lits molodogo vozrasta
Therapy. 2022;(S1):111-111
111-111
Manifestatsiya sakharnogo diabeta 2 tipa u molodykh patsientov do 30 let
Therapy. 2022;(S1):112-112
112-112
Rigidnost' sosudistoy stenki i interleykiny u bol'nykh arterial'noy gipertenziey i komorbidnymi zabolevaniyami
Therapy. 2022;(S1):112-113
112-113
Razrabotka novykh antibakterial'nykh preparatov na osnove antimikrobnykh peptidov
Therapy. 2022;(S1):113-113
113-113
Oksitotsin kak marker kognitivnykh narusheniy u patsientov s ishemicheskoy bolezn'yu serdtsa, gospitalizirovannykh dlya provedeniya aortokoronarnogo shuntirovaniya
Therapy. 2022;(S1):113-114
113-114
Vliyanie mal'nutritsii i starcheskoy astenii na vyzhivaemost' patsientov pozhilogo i starcheskogo vozrasta s khronicheskoy bolezn'yu pochek 3B-5 stadii
Therapy. 2022;(S1):114-115
114-115
Idti po sledu serdechno-sosudistoy patologii: polimorfnye varianty genov interleykina-10 i interleykina-17 u bol'nykh yazvennym kolitom na karandashe u kardiologov (pilotnoe issledovanie)
Therapy. 2022;(S1):115-115
115-115
Kardiometabolicheskie narusheniya na fone pul's-terapii u patsientov s rasseyannym sklerozom
Therapy. 2022;(S1):115-116
115-116
Izmeneniya mikrobioty kishechnika u perebolevshikh novoy koronavirusnoy infektsiey patsientov v Zabaykal'skom krae
Therapy. 2022;(S1):116-117
116-117
Sravnitel'naya kharakteristika porazheniya sustavov i entezisov verkhnikh i nizhnikh konechnostey u patsientov s vospalitel'nymi zabolevaniyami kishechnika
Therapy. 2022;(S1):117-117
117-117
Markery vospaleniya i pochechnaya disfunktsiya u patsientov s arterial'noy gipertenziey i sakharnym diabetom 2-go tipa
Therapy. 2022;(S1):117-118
117-118
K probleme effektivnogo kontrolya lecheniya ozhireniya
Therapy. 2022;(S1):118-118
118-118
Faktory kardiometabolicheskogo riska i osobennosti klinicheskogo techeniya gipertroficheskoy kardiomiopatii v zavisimosti ot vozrasta manifestatsii klinicheskikh proyavleniy
Therapy. 2022;(S1):119-119
119-119
Polimorfizm gena metalloproteinazy-9 u patsientov s sakharnym diabetom 1 i 2 tipa, imeyushchikh diabeticheskuyu polineyropatiyu i sindrom diabeticheskoy stopy
Therapy. 2022;(S1):119-120
119-120
Znachenie R-selektina v ranney diagnostike venoznykh trombozov u bol'nykh so zlokachestvennymi novoobrazovaniyami
Therapy. 2022;(S1):120-120
120-120
Vozrastnye i gendernye osobennosti disfunktsii pochek i lipidnogo spektra krovi pri gipertrofii levogo zheludochka
Therapy. 2022;(S1):121-121
121-121
Uroven' eozinofilii krovi u patsientov s chastymi obostreniyami khronicheskoy obstruktivnoy bolezni legkikh
Therapy. 2022;(S1):121-122
121-122
Osobennosti debyuta COVID-19-assotsiirovannoy pnevmonii u patsientov, vaktsinirovannykh ot COVID-19
Therapy. 2022;(S1):122-123
122-123
Angiograficheskaya otsenka koronarnogo rusla u patsientov s ostrym infarktom miokarda, razvivshimsya na fone COVID-19
Therapy. 2022;(S1):123-123
123-123
Sostoyanie miokarda v ostrom periode infarkta miokarda, razvivshimsya na fone COVID-19
Therapy. 2022;(S1):123-124
123-124
Problemy diagnostiki i lecheniya lokal'noy formy granulematoza s poliangiitom
Therapy. 2022;(S1):124-125
124-125
Molekulyarno-geneticheskie prediktory razvitiya i progressirovaniya antratsiklin-indutsirovannoy kardiotoksichnosti
Therapy. 2022;(S1):125-125
125-125
Dinamika naznacheniya antitromboticheskoy terapii u patsientov s fibrillyatsiey predserdiy, gospitalizirovannykh po povodu infarkta miokarda v 2016-2021 gg
Therapy. 2022;(S1):125-126
125-126
Vzaimosvyaz' parametrov kislotno-osnovnogo sostoyaniya i elektrolitnogo sostava krovi s pokazatelyami sistemnogo vospaleniya u bol'nykh khronicheskoy obstruktivnoy bolezn'yu legkikh i COVID-19
Therapy. 2022;(S1):126-127
126-127
Faktory, formiruyushchie priverzhennost' k farmakoterapii u patsientov s khronicheskoy serdechnoy nedostatochnost'yu v period pandemii COVID-19
Therapy. 2022;(S1):127-127
127-127
Khronicheskaya nekardial'naya patologiya i otdalennye iskhody u patsientov s kardiovaskulyarnoy mul'timorbidnost'yu, perenesshikh COVID-19
Therapy. 2022;(S1):128-128
128-128
Rasprostranennost' bessimptomnoy giperurikemii u patsientov s ostroy dekompensatsiey serdechnoy nedostatochnosti pri sakharnom diabete 2 tipa v zavisimosti ot skorosti klubochkovoy fil'tratsii
Therapy. 2022;(S1):128-129
128-129
Adaptirovannaya russkoyazychnaya versiya oprosnika MDASI-HF kak instrument otsenki kardiotoksichnosti, indutsirovannoy khimioterapiey, i ee vliyaniya na kachestvo zhizni patsientov s onkopatologiey
Therapy. 2022;(S1):129-129
129-129
Melatonin v klinike kislotozavisimykh zabolevaniy
Therapy. 2022;(S1):129-130
129-130
Usilennaya naruzhnaya kontrpul'satsiya kak sredstvo reabilitatsii patsientov s tyazhelymi ventilyatsionnymi narusheniyami
Therapy. 2022;(S1):130-131
130-131
Markery neytrofil'noy aktivatsii pri bolezni Bekhcheta
Therapy. 2022;(S1):131-131
131-131
Sroki razvitiya neeffektivnosti ingibitorov FNOα i ikh razlichiya u patsientov s immunovospalitel'nymi zabolevaniyami
Therapy. 2022;(S1):131-132
131-132
T-kletochnyy i gumoral'nyy otvet na COVID-19 u bol'nykh revmatoidnym artritom
Therapy. 2022;(S1):132-133
132-133
Nealkogol'naya zhirovaya bolezn' pecheni i metabolicheskiy sindrom u lits molodogo vozrasta
Therapy. 2022;(S1):133-133
133-133
Dinamika pokazateley arterial'noy rigidnosti u bol'nykh revmatoidnym artritom na fone terapii sinteticheskimi i targetnymi bazisnymi protivovospalitel'nymi preparatami
Therapy. 2022;(S1):133-134
133-134
Prognosticheskie markery techeniya koronavirusnoy infektsii COVID-19 s uchetom vozrasta, pola i komorbidnogo statusa patsienta
Therapy. 2022;(S1):134-135
134-135
Strakh padeniy kak modifitsiruemyy faktor riska padeniy u patsientov s arterial'noy gipertenziey
Therapy. 2022;(S1):135-135
135-135
Klinicheskie simptomy i uroven' ekstrakletochnykh neytrofil'nykh lovushek v krovi u patsientov molodogo vozrasta posle perenesennogo COVID-19
Therapy. 2022;(S1):135-136
135-136
Stratifikatsiya serdechno-sosudistogo riska u bol'nykh arterial'noy gipertenziey s sindromom obstruktivnogo apnoe sna i COVID-19 v anamneze
Therapy. 2022;(S1):136-136
136-136
Klinicheskiy sluchay khronicheskogo lokal'nogo razryva anevrizmy infrarenal'nogo otdela aorty s destruktivnymi izmeneniyami poyasnichnogo otdela pozvonochnika
Therapy. 2022;(S1):136-137
136-137
Mozhno li dietoy regulirovat' autofagiyu u cheloveka
Therapy. 2022;(S1):137-138
137-138
Klinicheskie stigmy sindroma razdrazhennogo kishechnika, assotsiirovannogo s ozhireniem i izbytochnoy massoy tela
Therapy. 2022;(S1):138-138
138-138
Mozhno li schitat' povyshennye pokazateli okruzhnosti talii i okruzhnosti beder, sootnosheniya okruzhnosti talii k okruzhnosti beder, insulinopodobnogo faktora rosta-1 prediktorami follikulyarnoy adenomy shchitovidnoy zhelezy?
Therapy. 2022;(S1):139-139
139-139
Ekhokardiograficheskie pokazateli patsientok s polimorfizmom Leu59Pro gena integrina beta - 3 (ITGB3)
Therapy. 2022;(S1):139-140
139-140
Fenotipy narusheniy arterial'nogo davleniya i ikh assotsiatsiya s perenesennoy novoy koronavirusnoy infektsiey
Therapy. 2022;(S1):140-140
140-140
Svyaz' kozhno-slizistoy patologii s kliniko-immunologicheskimi proyavleniyami sistemnoy krasnoy volchanki
Therapy. 2022;(S1):140-141
140-141
Personifitsirovannyy podkhod v lechenii patsientov s rezistentnoy arterial'noy gipertenziey
Therapy. 2022;(S1):141-141
141-141
Vzaimosvyaz' adipotsitokinov s markerami ranney renal'noy disfunktsii u bol'nykh s nealkogol'noy zhirovoy bolezn'yu pecheni
Therapy. 2022;(S1):141-142
141-142
Prognosticheskoe znachenie matriksnykh metalloproteinaz, ikh tkanevykh ingibitorov i markerov vospaleniya u patsientov s khronicheskoy serdechnoy nedostatochnost'yu
Therapy. 2022;(S1):142-143
142-143
Rol' disbalansa lipopolisakharid-svyazyvayushchikh sistem v patogeneze ostrogo SARS-CoV-2-porazheniya legkikh
Therapy. 2022;(S1):143-143
143-143